| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |